Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?
- PMID: 32198834
- PMCID: PMC7228209
- DOI: 10.1111/ajt.15874
Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?
Abstract
COVID-19 is novel infectious disease with an evolving understanding of its epidemiology and clinical manifestations. Immunocompromised patients often present atypical presentations of viral diseases. Herein we report a case of a COVID-19 infection in a solid organ transplant recipient, in which the first clinical symptoms were of gastrointestinal viral disease and fever, which further progressed to respiratory symptoms in 48 hours. In these high risk populations, protocols for screening for SARS-Cov2 may be needed to be re-evaluated.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.
Figures
Comment in
-
Immunosuppression drug-related and clinical manifestation of Coronavirus disease 2019: A therapeutical hypothesis.Am J Transplant. 2020 Jul;20(7):1947-1948. doi: 10.1111/ajt.15905. Epub 2020 Apr 15. Am J Transplant. 2020. PMID: 32243698 Free PMC article. No abstract available.
References
-
- World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 44. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
-
- Shelhamer JH, Toews GB, Masur H, et al. Respiratory disease in the immunosuppressed patient. Ann Intern Med. 1992;117(5):415–431. - PubMed
-
- Ventura-Aguiar P, Campistol JM, Diekmann F. Safety of mTOR inhibitors in adult solid organ transplantation. Expert Opin Drug Saf. 2016;15(3):303–319. - PubMed
-
- Ministerio de Sanidad. Gobierno de España. Enfermedad por el coronavirus (COVID-19) – Situación actual. https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual.... Accessed March 16, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
